Last reviewed · How we verify

NCT05644912

Exploratory Investigation on a Novel Catheter

Completed NA Last updated 24 April 2024
What this trial tests

NA trial testing Transanal irrigation (TAI) in Bowel Dysfunction in 13 participants. Completed in 15 December 2023.

Timeline
18 November 2022
Primary endpoint
15 December 2023
15 December 2023

Quick facts

Lead sponsorWellspect HealthCare
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment13
Start date18 November 2022
Primary completion15 December 2023
Estimated completion15 December 2023
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Wellspect HealthCare

Who can join

Adults 18 to 80, any sex, with Bowel Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

An exploratory, pre-market, open, prospective, interventional, clinical investigation at a limited number of centers for proof of concept of a new catheter. In this proof of concept investigation, subjects experienced in using transanal irrigation (TAI) with a balloon catheter will be using study catheters at two occasions to primarily study if the catheter will stay in place during the water instillation when performing TAI. Each subject will be followed during approximately one week, depending on the usual time between their TAI.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Bowel Dysfunction

Currently open trials in the same condition.

Other Wellspect HealthCare trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05644912.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing